TCTR20190205002
Recruiting
Phase 4
Effects of Vitamin C, Vitamin D3, Coenzyme Q10 and antioxidant formula of different supplement forms on micronutrient, biomarker blood levels and quality of life.
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Different formula of supplement on micronutrient,
- Sponsor
- A
- Enrollment
- 72
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Subjects aged ≥ 18 years who visit Vital\-life wellness center for micronutrient level assessment and decide to receive either Vitamin C, Vitamin D3, CO\-Q10 and antioxidant formula of HCK® or The original VTL supplement of Vitamin C, Vitamin D3, CO\-Q10 and antioxidant or no supplement after discussion for possible treatment options with physician as usual practice
- •2\.Subjects found to have low level of 25\-(OH)D3/D2 (having 25\-(OH)D3/D2 level 20\-29 ng/ml) with the symptoms or feelings of low energy, lack of vitality or tiredness
- •3\.Subjects who have not taken coenzyme Q10, vitamin C, vitamin D3, vitamin E, carotenoids, and flavonoids for at least 3 months and vitamin A for at least 6 months
- •4\.Willing and able to comply with study procedure.
Exclusion Criteria
- •1\.Subjects with poorly controlled underlying diseases such as poor control of Blood
- •Pressure (systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 110 mmHg), poor control of blood sugar (HbA1c \> 7%).
- •2\.Subjects with eGFR \< 30 ml/min/1\.73 m2
- •3\.Female subjects who are pregnant or lactating, or plan to have children (a negative
- •serum or urine pregnancy test is required on the screening day for women of child\-bearing potential).
- •4\. Subjects with diseases that may interfere with supplement absorption e.g., patients
- •with malabsorption and bowel surgery.
- •5\. Subjects using medication that may interfere with micronutrient levels such as acid
- •suppressants, antacids, antiepileptic drugs (i.e., phenobarbital, valproic acid,
- •carbamazepine, phenytoin), and antipsychotic drugs (i.e., tricyclic antidepressants and
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Role of antioxidants in newborns failing to initiate breathing at birthHealth Condition 1: null- Birth asphyxiaCTRI/2013/02/003379Government Medical College Bhavnagar95
Not yet recruiting
Phase 3
Investigating the Effect of Vitamins E, C and D on Symptoms of Withdrawal SyndromeAnxiety and pain caused by drug withdrawal in addicted patients.Mental and behavioural disorders due to multiple drug use and use of other psychoactive substancesF19.3IRCT20200721048159N6Khoram-Abad University of Medical Sciences125
Not yet recruiting
Phase 2
Treatment of distal radius fracturesFracture at wrist and hand level.Fracture at wrist and hand levelIRCT20211201053235N6Shahid Beheshti University of Medical Sciences60
Completed
Phase 3
Effect of vitamin supplementation on pulmonary fibrosis patientspulmonary fibrosis.Other interstitial pulmonary diseases with fibrosisIRCT201612202365N15Iran University of Medical Sciences36
Completed
Not Applicable
Effects of a combined Vitamin D, Omega 3, Co-enzyme Q10, Zeaxanthin, Lutein and Astaxanthin supplement (Lester’s Oil) on Healthy peopleInflammationFatty acid profilesDiet and Nutrition - Other diet and nutrition disordersInflammatory and Immune System - Normal development and function of the immune systemACTRN12616001316493niversity of Auckland30